Results 21 to 30 of about 430,558 (143)
Distribution of CA 125 in Placental Tissues
The International Journal of Biological Markers, 1989 The presence of the tumor marker CA 125 was studied in different compartments of the human placenta. Levels of CA 125 in the cytosol of chorionic villi ranged from 27 - 17100 U/g (median 560 U/g). In the placental amnion and chorion concentrations ranged
L.C. Fuith +5 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2021 Background and Aims: Patients with light-chain cardiac amyloidosis (AL-CA) are characterized by high levels of serum carbohydrate antigen 125 (CA 125). However, studies have not explored the correlation between CA 125 and AL-CA. The aim of this study was
Muzheng Li +14 more
doaj +1 more source
Indonesian Journal of Cancer, 2012 Tujuan: Mengetahui dan membandingkan sensitivitas, spesifisitas, Positive Predictive Value, dan Negative Predictive Value antara HE4, CA-125, serta kombinasi HE4 dan CA-125 sebagai tumor marker pada pasien kanker ovarium tipe epitel.
PUNGKY MULAWARDHANA +2 more
doaj +1 more source
Tumour Associated Antigens CA 15.3 and CA 125 in Ovarian Cancer
The International Journal of Biological Markers, 1991 CA 125 and CA 15.3 antigens were determined by enzyme immunoassay in 78 patients with ovarian cancer for a total of 540 determinations. The antigens were also investigated in sera from 100 women with other gynaecological diseases, 82 lung cancer patients
M. Lotzniker +5 more
doaj +1 more source
CA 125: The past and the Future
The International Journal of Biological Markers, 1998 Over the last 15 years, substantial progress has been made in understanding the potential and the limitations of the CA 125 assay. More than 2000 papers have been published concerning laboratory and clinical studies of CA 125.
R.C. Bast +5 more
doaj +1 more source
CA‐125 variation in acute heart failure: a single‐centre analysis
ESC Heart Failure, 2022 Aims A decrease in carbohydrate antigen 125 (CA‐125) predicts survival advantage in chronic heart failure (HF); the impact of its variation in acute HF is unknown. We studied the association of CA‐125 decrease with prognosis in acute HF.
Patrícia Lourenço +6 more
doaj +1 more source
Carbohydrate Antigen 125 Is a Biomarker of the Severity and Prognosis of Pulmonary Hypertension
Frontiers in Cardiovascular Medicine, 2021 Background: Emerging evidence has showed that serum carbohydrate antigen 125 (CA 125) levels are associated with the severity and prognosis of heart failure. However, its role in pulmonary hypertension remains unclear. This study aimed to investigate the
Yi Zhang +14 more
doaj +1 more source
Forum Médical Suisse ‒ Swiss Medical Forum, 2019 Actuellement, le depistage par CA 125 et ultrason endovaginal n’est pas recommande pour la population generale. Il y a cependant des patientes qui peuvent beneficier d’un programme de depistage.
Gros, Louis +2 more
openaire +2 more sources
Gynecologic Oncology Reports, 2017 We describe the case of a 67 year old female with longstanding uterine leiomyomas who presented with fatigue, weight loss, elevated CA-125 and an enlarging mass arising from the posterior uterine fundus.
Sarah V. Strickland +3 more
doaj +1 more source
Serum levels of carbohydrate antigen 125 in combination with N-terminal pro-brain natriuretic peptide in patients with acute decompensated heart failure [PDF]
The Korean Journal of Internal Medicine, 2019 Background/Aims Carbohydrate antigen 125 (CA-125) is an emerging prognostic biomarker for heart failure. We aimed to test the long-term prognostic value of CA-125 in combination with N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with ...
Jae Yong Yoon +12 more
doaj +1 more source